Sangamo Therapeutics Ownership | Who Owns Sangamo Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Sangamo Therapeutics Ownership Summary


Sangamo Therapeutics is owned by 26.84% institutional investors, 2.38% insiders, and 70.78% retail investors. Wasatch advisors lp is the largest institutional shareholder, holding 11.14% of SGMO shares. Wasatch Ultra Growth is the top mutual fund, with 5.27% of its assets in Sangamo Therapeutics shares.

SGMO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSangamo Therapeutics26.84%2.38%70.78%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Wasatch advisors lp20.09M11.14%$7.20M
Vanguard group11.90M6.60%$4.26M
Blackrock4.70M2.61%$1.69M
Renaissance4.13M2.29%$1.48M
Jacobs levy equity management2.95M1.64%$1.06M
Millennium management2.41M1.34%$862.86K
Geode capital management1.87M1.03%$668.80K
Goldman sachs group1.33M0.74%$477.78K
Northern trust1.20M0.67%$430.33K
D. e. shaw1.17M0.65%$417.78K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Golden state equity partners325.68K0.06%$332.20K
Wasatch advisors lp20.09M0.04%$7.20M
Gsa capital partners llp933.18K0.02%$334.00K
Point72 asia (singapore) pte.247.87K0.02%$88.81K
Shelton wealth management28.00K0.01%$28.56K
Founders capital management14.00K0.01%$14.28K
Sandbox financial partners24.83K0.01%$25.33K
Lji wealth management24.26K0.00%$24.75K
Jacobs levy equity management2.95M0.00%$1.06M
Sageworth trust60.00K0.00%$61.20K

Top Buyers

HolderShares% AssetsChange
Jacobs levy equity management2.95M0.00%2.76M
Renaissance4.13M0.00%1.53M
Millennium management2.41M0.00%1.30M
Goldman sachs group1.33M0.00%700.83K
Gsa capital partners llp933.18K0.02%568.89K

Top Sellers

HolderShares% AssetsChange
Armistice capital---14.06M
Blackrock4.70M--8.57M
Acadian asset management---4.56M
State street519.22K--2.23M
D. e. shaw1.17M0.00%-1.90M

New Positions

HolderShares% AssetsChangeValue
Point72 asia (singapore) pte.247.87K0.02%247.87K$88.81K
Cubist systematic strategies185.81K0.00%185.81K$66.58K
Sageworth trust60.00K0.00%60.00K$61.20K
Shelton wealth management28.00K0.01%28.00K$28.56K
Victory capital management24.10K-24.10K$8.63K

Sold Out

HolderChange
Gps wealth strategies group-100.00
Capital performance advisors llp-200.00
Umb bank, n.a.-200.00
Nisa investment advisors-285.00
Planned solutions-300.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 2024111-13.28%55,928,091-35.58%261.16%41-28.07%33-23.26%
Jun 30, 2024128-3.03%86,818,721-14.00%481.54%577.55%43-12.24%
Mar 31, 20241320.76%100,948,72016.17%552.34%53-13.11%4913.95%
Dec 31, 2023131-2.96%86,900,000-15.17%481.45%6141.86%43-12.24%
Sep 30, 2023135-11.18%102,442,309-3.26%581.57%43-35.82%4916.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Wasatch Ultra Growth10.97M5.27%-841.51K
Vanguard Total Stock Mkt Idx Inv5.99M2.87%339.20K
Wasatch Micro Cap5.65M2.71%359.34K
SPDR® S&P Biotech ETF3.83M1.83%-14.17K
Vanguard Institutional Extnd Mkt Idx Tr3.07M1.47%63.47K
Vanguard Strategic Small-Cap Equity Inv1.71M0.82%-
Vanguard Explorer Inv1.40M0.67%-
Fidelity Extended Market Index1.06M0.51%-2.53K
Schwab US Small-Cap ETF™921.84K0.44%-1.17K
Vanguard Health Care ETF657.01K0.31%-1.71K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 26, 2023BIOGEN INC.-Sell$3.00M
Aug 29, 2022BIOGEN INC.-Sell$2.13M
Aug 30, 2022BIOGEN INC.-Sell$526.52K
Aug 29, 2022Biogen MA Inc. Sell$526.52K
Aug 29, 2022Biogen MA Inc. Sell$2.13M

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q4--
2024 Q3--
2024 Q2--
2024 Q1--

SGMO Ownership FAQ


Who Owns Sangamo Therapeutics?

Sangamo Therapeutics shareholders are primarily institutional investors at 26.84%, followed by 2.38% insiders and 70.78% retail investors. The average institutional ownership in Sangamo Therapeutics's industry, Biotech Stocks , is 109.70%, which Sangamo Therapeutics falls below.

Who owns the most shares of Sangamo Therapeutics?

Sangamo Therapeutics’s largest shareholders are Wasatch advisors lp (20.09M shares, 11.14%), Vanguard group (11.9M shares, 6.60%), and Blackrock (4.7M shares, 2.61%). Together, they hold 20.35% of Sangamo Therapeutics’s total shares outstanding.

Does Blackrock own Sangamo Therapeutics?

Yes, BlackRock owns 2.61% of Sangamo Therapeutics, totaling 4.7M shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.69M$. In the last quarter, BlackRock decreased its holdings by -8.575M shares, a -64.58% change.

Who is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested?

Golden state equity partners is Sangamo Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.06% of its assets in 325.68K Sangamo Therapeutics shares, valued at 332.2K$.

Who is the top mutual fund holder of Sangamo Therapeutics shares?

Wasatch Ultra Growth is the top mutual fund holder of Sangamo Therapeutics shares, with 5.27% of its total shares outstanding invested in 10.97M Sangamo Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools